Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

23.76
0.0000
Volume:273
Turnover:6.34K
Market Cap:4.28M
PE:- -
High:23.76
Open:23.76
Low:23.76
Close:23.76
52wk High:34.36
52wk Low:19.00
Shares:180.00K
Float Shares:180.00K
Volume Ratio:0.87
T/O Rate:0.15%
Dividend:1.69
Dividend Rate:7.13%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo CEO Urges Staff to Embrace More Customer-Focused Culture

Reuters
·
1 hour ago

Sector Update: Healthcare

MT Newswires Live
·
2 hours ago

Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

TIPRANKS
·
3 hours ago

Lilly: Foundayo Has Captured Over 30% Of New Patient Share In The U.S. Oral Weight-Loss Drug Market

Bellwether Stocks Movement
·
4 hours ago

Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

TIPRANKS
·
5 hours ago

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
7 hours ago

Lilly's Foundayo Grabs 30% Of New U.S. Orforglipron Patients, Chipping Away At Novo's Head Start

Options & Short Sell
·
12 hours ago

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
19 hours ago

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
20 hours ago

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
23 hours ago

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Yesterday

Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

TIPRANKS
·
Yesterday

Data Retention Terms Prompt Restraints on AI Model Use for Sensitive Operations

Deep News
·
Yesterday

Novo Signals New Direction of Travel with Rebrand

Dow Jones
·
Yesterday

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Yesterday

Novo Nordisk to Rebrand as Novo

Dow Jones
·
Yesterday

GE HealthCare Plans $1 Billion Sofie Deal To Tap Fast-Growing Radiopharmaceuticals Market

Options & Short Sell
·
Yesterday

Novo Nordisk Stock Slides as GLP-1 Fears Mount

TIPRANKS
·
Sep 12

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains

ETF Weekly
·
Sep 12